ID

30561

Description

A Study to Determine the Efficacy and Safety of Lenalidomide in Patients With Mantle Cell NHL Who Have Relapsed or Progressed After Treatment With Bortezomib or Are Refractory to Bortezomib. The "EMERGE" Trial; ODM derived from: https://clinicaltrials.gov/show/NCT00737529

Link

https://clinicaltrials.gov/show/NCT00737529

Keywords

Versions (1)
  1. 6/14/18 6/14/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

June 14, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

No comments

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Mantle Cell Lymphoma NCT00737529

English

Eligibility Mantle Cell Lymphoma NCT00737529

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
biopsy proven mantle cell lymphoma
Description

Mantle cell lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C0334634
patients must have documents relapsed, refractory or pd after treatment with bortezomib
Description

Bortezomib | Recurrent disease | Refractory Disease | Progressive Disease

Data type

boolean

Alias
UMLS CUI [1]
C1176309
UMLS CUI [2]
C0277556
UMLS CUI [3]
C1514815
UMLS CUI [4]
C1335499
must have measureable disease on cross sectional imaging by ct
Description

Measurable Disease Cross-sectional imaging CT

Data type

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C3824793
UMLS CUI [1,3]
C0040405
eastern cooperative oncology group (ecog) performance score 0,1 or 2
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
willing to follow pregnancy precautions
Description

Contraceptive methods Willing

Data type

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C0600109
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
any of the following laboratory abnormalities
Description

Laboratory test result abnormal

Data type

boolean

Alias
UMLS CUI [1]
C0438215
absolute neutrophil count (anc) < 1,500 cells/mm3 (1.5 x 109/l)
Description

Absolute neutrophil count

Data type

boolean

Alias
UMLS CUI [1]
C0948762
platelet count < 60,000/mm3 (60 x 109/l)
Description

Platelet Count measurement

Data type

boolean

Alias
UMLS CUI [1]
C0032181
serum aspartate transaminase/serum glutamic oxaloacetic transaminase(ast/sgot) or alanine transaminase/serum glutamic pyruvic transaminase (alt/sgpt) > 3.0 x upper limit of normal (uln), except in patients with documented liver involvement by lymphoma.
Description

Aspartate aminotransferase increased | Alanine aminotransferase increased | Exception Liver Involvement with Lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C0151904
UMLS CUI [2]
C0151905
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0023884
UMLS CUI [3,3]
C1314939
UMLS CUI [3,4]
C0024299
serum total bilirubin > 1.5 x uln, except in cases of gilbert's syndrome and documented liver involvement by lymphoma.
Description

Elevated total bilirubin | Exception Gilbert Disease | Exception Liver Involvement with Lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C0741494
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0017551
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0023884
UMLS CUI [3,3]
C1314939
UMLS CUI [3,4]
C0024299
calculated creatinine clearance (cockcroft-gault formula) of < 30 ml /min
Description

Estimation of creatinine clearance by Cockcroft-Gault formula

Data type

boolean

Alias
UMLS CUI [1]
C2711451
patients who are candidates for high dose chemotherapy/allogeneic stem cell transplant are not eligible
Description

Patient need for High-dose chemotherapy | Patient need for Allogeneic Stem Cell Transplantation

Data type

boolean

Alias
UMLS CUI [1,1]
C0686904
UMLS CUI [1,2]
C1328050
UMLS CUI [2,1]
C0686904
UMLS CUI [2,2]
C2242529
history of active central nervous system (cns) lymphoma within the previous 3 months
Description

Central nervous system lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C0742472
subjects not willing or unable to take deep vein thrombosis (dvt) prophylaxis
Description

DVT prophylaxis Unwilling | DVT prophylaxis Unable

Data type

boolean

Alias
UMLS CUI [1,1]
C0853245
UMLS CUI [1,2]
C0558080
UMLS CUI [2,1]
C0853245
UMLS CUI [2,2]
C1299582
prior history of malignancies, other than mcl, unless the patient has been free of the disease for ≥ 3 years
Description

Malignant Neoplasms | Exception Mantle cell lymphoma | Exception Disease Free of

Data type

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0334634
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0012634
UMLS CUI [3,3]
C0332296
positive human immunodeficiency virus (hiv) or active hepatitis b or c
Description

HIV Seropositivity | Hepatitis B | Hepatitis C

Data type

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2]
C0019163
UMLS CUI [3]
C0019196
Back to the top of the page

Similar models

Eligibility Mantle Cell Lymphoma NCT00737529

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Mantle cell lymphoma
Item
biopsy proven mantle cell lymphoma
boolean
C0334634 (UMLS CUI [1])
Bortezomib | Recurrent disease | Refractory Disease | Progressive Disease
Item
patients must have documents relapsed, refractory or pd after treatment with bortezomib
boolean
C1176309 (UMLS CUI [1])
C0277556 (UMLS CUI [2])
C1514815 (UMLS CUI [3])
C1335499 (UMLS CUI [4])
Measurable Disease Cross-sectional imaging CT
Item
must have measureable disease on cross sectional imaging by ct
boolean
C1513041 (UMLS CUI [1,1])
C3824793 (UMLS CUI [1,2])
C0040405 (UMLS CUI [1,3])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance score 0,1 or 2
boolean
C1520224 (UMLS CUI [1])
Contraceptive methods Willing
Item
willing to follow pregnancy precautions
boolean
C0700589 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Laboratory test result abnormal
Item
any of the following laboratory abnormalities
boolean
C0438215 (UMLS CUI [1])
Absolute neutrophil count
Item
absolute neutrophil count (anc) < 1,500 cells/mm3 (1.5 x 109/l)
boolean
C0948762 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count < 60,000/mm3 (60 x 109/l)
boolean
C0032181 (UMLS CUI [1])
Aspartate aminotransferase increased | Alanine aminotransferase increased | Exception Liver Involvement with Lymphoma
Item
serum aspartate transaminase/serum glutamic oxaloacetic transaminase(ast/sgot) or alanine transaminase/serum glutamic pyruvic transaminase (alt/sgpt) > 3.0 x upper limit of normal (uln), except in patients with documented liver involvement by lymphoma.
boolean
C0151904 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0023884 (UMLS CUI [3,2])
C1314939 (UMLS CUI [3,3])
C0024299 (UMLS CUI [3,4])
Elevated total bilirubin | Exception Gilbert Disease | Exception Liver Involvement with Lymphoma
Item
serum total bilirubin > 1.5 x uln, except in cases of gilbert's syndrome and documented liver involvement by lymphoma.
boolean
C0741494 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0017551 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0023884 (UMLS CUI [3,2])
C1314939 (UMLS CUI [3,3])
C0024299 (UMLS CUI [3,4])
Estimation of creatinine clearance by Cockcroft-Gault formula
Item
calculated creatinine clearance (cockcroft-gault formula) of < 30 ml /min
boolean
C2711451 (UMLS CUI [1])
Patient need for High-dose chemotherapy | Patient need for Allogeneic Stem Cell Transplantation
Item
patients who are candidates for high dose chemotherapy/allogeneic stem cell transplant are not eligible
boolean
C0686904 (UMLS CUI [1,1])
C1328050 (UMLS CUI [1,2])
C0686904 (UMLS CUI [2,1])
C2242529 (UMLS CUI [2,2])
Central nervous system lymphoma
Item
history of active central nervous system (cns) lymphoma within the previous 3 months
boolean
C0742472 (UMLS CUI [1])
DVT prophylaxis Unwilling | DVT prophylaxis Unable
Item
subjects not willing or unable to take deep vein thrombosis (dvt) prophylaxis
boolean
C0853245 (UMLS CUI [1,1])
C0558080 (UMLS CUI [1,2])
C0853245 (UMLS CUI [2,1])
C1299582 (UMLS CUI [2,2])
Malignant Neoplasms | Exception Mantle cell lymphoma | Exception Disease Free of
Item
prior history of malignancies, other than mcl, unless the patient has been free of the disease for ≥ 3 years
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0334634 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0012634 (UMLS CUI [3,2])
C0332296 (UMLS CUI [3,3])
HIV Seropositivity | Hepatitis B | Hepatitis C
Item
positive human immunodeficiency virus (hiv) or active hepatitis b or c
boolean
C0019699 (UMLS CUI [1])
C0019163 (UMLS CUI [2])
C0019196 (UMLS CUI [3])
Back to the top of the page 

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial